Delivery Order SPE2DB22D2206-SPE2DB24FHH28

Award Date 5/20/24
Potential Completion Date 5/21/24
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,437.70 firm fixed-price delivery order is for the supply of 4566947370 CEFPODOXIME 200 MG TABLET 20S. The contract has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
This federal contract award, valued at $2,156.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEFPODOXIME 200 MG TABLET 20S, a pharmaceutical product, with a period of performance through February 20, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,437.70, is for the delivery of CEFPODOXIME 200 MG TABLET 20S, a prescription medication. This is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of August 8, 2024. Amerisourcebergen Drug Corp is a for-profit organization that provides a wide...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,291.45 firm fixed-price delivery order is for the supply of CEFPODOXIME 200 MG TABLET 20S, a pharmaceutical product. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
This federal contract award, valued at $1,624.71, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of CEFPODOXIME 200 MG TABLET 20S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of April 19, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,831.98 firm fixed-price delivery order is for the supply of 4567343227 CEFPODOXIME 200 MG TABLET 20S, with a period of performance through February 24, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a $1,313.65 delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564328059 CEFPODOXIME 200 MG TABLET 20S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a wide range of pharmaceutical products and...
This federal contract award, valued at $2,117.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of CEFPODOXIME 200 MG TABLET 20S, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of September 5, 2024. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., involves the delivery of CEFPODOXIME 100 MG TABLET 20S for the Defense Logistics Agency (DLA). The $2,316.05 Firm Fixed Price Delivery Order has an ultimate completion date of April 26, 2024. This contract award is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award is for the delivery of 4,565,751,351 units of the pharmaceutical product CEFPODOXIME 100 MG TABLET 20S. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,290.60 and an ultimate completion date of September 11, 2024. The contract does not have a set-aside...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FHH28
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of CEFPODOXIME 200 MG TABLET 20S. The $2,687.22 firm fixed price delivery order has a completion date of May 21, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's extensive federal contract portfolio demonstrates its critical role in supplying essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other medical supplies, to various U.S. government agencies and military healthcare systems.

Generated 5/16/25, 11:50 AM